Remove Disease Remove Presentation Remove Radiation Oncology
article thumbnail

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

Imaging Technology

The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. Amsbaugh; Catherine S.

article thumbnail

ASTRO: IMRT and proton therapy equally effective for prostate cancer

AuntMinnie

Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting. each year – are diagnosed as localized disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Promise of Automation in Radiation Oncology

The British Institute of Radiology

Radiation oncology clinics face numerous challenges in the present environment, including the simultaneous management of multiple tasks (many of which are manual in nature), various degrees of standardisation, and the potential for errors to impact patient treatment. per week for curative diseases.

article thumbnail

Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting

Imaging Technology

Heisler Associate Professor for Lung Cancer Excellence, is the chair of the Cancer Communications Committee and an incoming elected member of the Nominating Committee; and Neha Vapiwala, MD, FASCO , a professor of Radiation Oncology, is an elected member of the Nominating Committee. Also, Lynn M. CT in Room E451. CT in S100bc.

Clinic 111
article thumbnail

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Imaging Technology

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Presenter: Ashesh B.

article thumbnail

ASTRO: Lu-177 dotatate shows promise for treating meningioma patients

AuntMinnie

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting.

article thumbnail

ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

Imaging Technology

The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.